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ABSTRACT 
  
 
Objectives:     The incidence of esophageal adenocarcinoma (EAC) is increasing while 
adenocarcinoma of the stomach is decreasing.  We have investigated whether the 
incidences of these two cancers and their time trends might be inversely related pointing to a 
common environmental factor exerting opposite effects on these cancers. 
 
Methods: For cross-sectional analyses data were abstracted from “Cancer Incidence in Five 
Continents” (CI5) Volume X and GLOBOCAN 2012.  Relevant ICD-10 codes were used to 
locate esophageal and gastric cancers anatomically, and ICD-O codes for the histological 
diagnosis of EAC.  For longitudinal analyses age standardised rates (ASR) of EAC and total 
gastric cancer (TGC) were extracted from CI5C-Plus. 
 
Results: Estimated (2012) ASRs were available for 51 countries and these showed 
significant negative correlations between EAC and both TGC (males: CC=-0.38, p=0.006, 
females: CC=-0.41, p=0.003) and non-cardia gastric cancer rates (males CC= -0.41, 
p=0.003 and females CC=-0.43, p=0.005).  Annual incidence trends were analysed for                       
38 populations through 1989-2007 and showed significant decreases for TGC in 89% and 
increases for EAC in 66% of these, with no population showing a fall in the latter. Significant 
negative correlation between the incidence trends of the two cancers was observed in 28 of 
the 38 populations over the 19-50 years of available paired data.  Super-imposition of the 
longitudinal and cross-sectional data indicated that populations with a current high incidence 
of EAC and low incidence of gastric cancer had previously resembled countries with a high 
incidence of gastric cancer and low incidence of EAC.   
 
Conclusion: The negative association between gastric cancer and EAC in both current 
incidences and time trends is consistent with a common environmental factor predisposing 
to one and protecting from the other.   
 
Key words:  Esophageal adenocarcinoma, Gastric cancer, Incidence, Negative correlation, 
Epidemiology, Atrophic gastritis,  Helicobacter pylori.   
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STUDY HIGHLIGHTS 
 
 
WHAT IS CURRENT KNOWLEDGE 
- The incidence of esophageal adenocarcinoma (EAC) is increasing rapidly in Western 
populations. 
 
- The incidence of gastric cancer is decreasing throughout the world. 
 
 
WHAT IS NEW HERE 
 
- We have demonstrated an inverse relationship between the current incidences of 
those two cancers for countries throughout the world. 
 
- We have demonstrated an inverse relationship between the incidence trends of the 
two cancers within individual cancer registries. 
 
- Countries with a current high incidence of EAC and low incidence of gastric cancer 
previously resembled countries with a current low incidence of EAC and high 
incidence of gastric cancer. 
 
 
- The inverse association between these two cancers is consistent with changes in the 
prevalence of a common environmental factor predisposing to one and protecting 
from the other.  
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INTRODUCTION 
     Over the past three decades, esophageal adenocarcinoma (EAC) has been one of the 
fastest increasing malignancies in many countries1,2.  The cancer is thought to be the result 
of gastroesophageal reflux damaging the distal esophagus and causing columnar 
metaplasia often with intestinal phenotype.  This Barrett’s mucosa has an increased risk of 
progressing to dysplasia and adenocarcinoma. 
     The environmental factors causing the recent marked increase in incidence of EAC are 
unclear.  Central obesity is associated with both reflux and EAC and the increasing 
prevalence of obesity is likely to explain some of the rise in incidence of EAC (3,4).       
Smoking is another well-established risk factor for esophageal adenocarcinoma 5.  However, 
the prevalence of smoking has decreased over more than six decades in most Western 
countries and thus this cannot account for more recent increases in incidence of esophageal 
adenocarcinoma 6.    
     Another possible explanation is that H.pylori infection has been protecting against acid 
reflux, and thus EAC, and this is being lost by the falling incidence of the infection7.  There is 
a well-established negative association between H.pylori infection and both 
gastroesophageal reflux and EAC.8,9    This negative association between H.pylori and EAC 
is independent of the other risk factors of EAC including smoking and BMI10.  A proposed 
mechanism for the protective effect of H.pylori is that the gastritis induced by it may cause 
atrophy and reduced acid secretory capacity of the gastric mucosa.  As the acidity of the 
gastric juice is its main damaging component, reduction of this by H.pylori would protect 
against reflux-induced esophageal damage and associated adenocarcinoma11.   
     H. pylori atrophic gastritis is the major risk factor for non-cardia gastric cancer (NGGC)(12).   
If H.pylori infection does protect against EAC by inducing atrophy and reduced acid secretion, there 
should be a negative association between NCGC and EAC at a population level as the gastric 
mucosal changes predisposing to gastric cancer would be the same as those protecting from EAC.  
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Opposing incidence trends for EAC and NCGC have been reported in a study of the population of the 
East of England 
(13)
. 
     This study examined the relationship between the current incidences of the two cancers 
in different geographical regions of the world.  In addition, we studied the relation between 
changes in incidence of the two cancers over time.   
 
MATERIALS & METHODS 
 
Cross-Sectional Studies    
 
     Based on data from Cancer Incidence in Five Continents Vol. X (CI5X) 14 and 
GLOBOCAN 2012 15, age-specific and age-standardized (world population) incidence rates 
(WASR) were estimated for EAC and gastric cancer by topographical subsite (cardia and 
non-cardia) in 2012. This method has been described in more detail by Arnold et al.16 and 
Colquhoun et al.17  In brief, sex- and age-specific (<65; ≥65 years) proportions of EAC were 
computed for all countries included in CI5X except for those with no cases of EAC in one of 
four substrata (male, female; <65, ≥65 years) (N=51). Similarly, the proportions of cardia 
cancer (C16.0) and NCGC (C16.1-6) cases out of all gastric cancers with known topography 
(C16.0-6) were calculated for each country included in CI5X and stratified by sex and the 
same broad age groups, provided there were two or more cases of cardia cancer (CGC) and 
NCGC within each sex and age group stratification. Where there were multiple datasets 
(from different regional cancer registries within a country), cases and populations were 
pooled to obtain estimated national proportions. The histological types of esophageal cancer 
and the topographical classification of gastric cancers were defined according to the third 
edition of the International Classification of Diseases for Oncology (ICD-O-3) presented in 
Cancer Incidence in Five Continents Vol. IX (CI5IX) 18,19. For this analysis, the national or 
regional proportions of CGC/NCGC and EAC cases determined in the previous steps were 
applied to the 2012 gastric and EAC incidence estimates in GLOBOCAN 2012. Age-
standardized incidence rates were computed using the world standard population (Table 1). 
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Longitudinal Studies 
 
     For the longitudinal study, WASR of EAC and total gastric cancer (TGC) were extracted 
from Cancer Incidence in Five Continents-Plus (CI5-plus) 1.  Cardia and non-cardia subsite 
data were not used because there were few longitudinal data for the specific subsite and 
also because there have been continuous changes in the subsite assignation practices for 
gastric cancer in histopathology laboratories.  A total of 38 populations around the world 
were selected for this study based on a) availability of data of esophageal cancer recorded 
by histology, b) a time period of at least 19 years ending in 2007, c) if separate datasets 
were available for ethnic groups, at least one dataset per ethnic group was selected. The 
incidence (WASR) of EAC and TGC at the start year (different for each registry), year 1989 
(earliest time common for all populations) and year 2007 (end year) were reported in Table 
2, for men and women separately. 
 
Statistical Analyses 
 
     For the cross-sectional study, Spearman’s rho correlations were used to explore the 
relationship between WASR of the two cancers. In the longitudinal study, in addition to 
Spearman’s rho correlations for pairwise correlation of EAC and TGC, time trends for 
individual registries, regression modelling was used to estimate the degree of incidence 
changes over time as described by Kim et al 20.  Briefly, using Joinpoint Programme version 
4.1.0 (National Cancer Institute, USA) we analysed the time trend data for each cancer, in 
each registry, in men and women individually (38 x2 x2= 152 datasets). The programme 
fitted the simplest Joinpoint model that the data allowed. The models used the log of the 
WASR for calculating the average annual percent change (AAPC) in rates and their 
corresponding 95% confidence intervals.  When any comparisons were made between 
different populations, the AAPC was always limited to the same 19 year period (1989-2007).  
When correlations were made between the change of cancer incidence between the two 
cancers within the same population, we present this in two different forms, firstly for the full 
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length of available longitudinal data for each population and secondly, limiting it to the same 
common observation period (1989-2007). 
     As EAC is much more common in men, we have focused mainly on results for men within 
the main text but have provided comparable analyses for women in the supplement. 
 
RESULTS 
 
A. Cross-sectional Study of National data     
 
     Incidence rate estimates were available for 51 countries (Table 1).  There was a wide 
range in the rates of both gastric cancer and EAC across these different countries.  The 
incidence of EAC varied from 0.23 per 100,000 person-years to 7.24.  The incidence of TGC 
varied from 2.84 to 62.26 and that of NCGC from 1.75 to 58.64. In general terms, gastric 
cancer incidence was highest in East Asia and lowest in Western Europe and North America 
whereas EAC showed the opposite trend.  In all 51 countries except the UK, EAC incidence 
rates were lower than the TGC rates and in 43 of 51 countries also lower than the NCGC 
incidence rate.    
          Statistically significant negative correlations between the incidence rates of EAC and 
both TGC {men (CC= -0.38, p=0.006), women (CC= -0.41, p=0.003)} and NCGC incidence 
{men (CC= -0.41, p=0.003) and women (CC= -0.43, p=0.005)} were observed.    
     The wide range in incidence of both EAC and TGC together with their inverse correlation 
resulted in a more than 200-fold range in the ratios of TGC to EAC across the different 
countries (more than 200:1 for the Republic of Korea to less than 1:1 for the UK)   
    Despite the strong negative correlation between the incidence rates of the two cancers, 
inspection of the data points indicated that in two respects the correlation was not linear (Fig. 
1a.b).  Firstly, the incidence of EAC seemed to be at a similar low level for all countries with 
moderate or high gastric cancer incidence and with a progressive rise in incidence at lower 
gastric cancer levels.  The incidence of TGC below which the rise in EAC was apparent was 
approximately 15 per 100,000p/y in men (Fig. 1) and 7.5 per 100,000p/y in women (Fig. 
S1a,b).  Secondly, when the incidence of TGC was low, the level of EAC incidence varied 
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considerably between countries with some showing marked elevation, some moderate and 
some no elevation. The equivalent figures for women showed a similar pattern though this 
was less clear due to much lower incidence rates (see Fig. S1a,b in supplement).   
      In order to investigate further the geographical distribution of the countries according to 
their TGC and EAC incidence rates, we sub-divided them into 4 groups  (Fig. 1c).  In men, 
the first 3 groups consisted of countries with low TGC incidence (<15 per 100,000 p/y) and 
EAC incidence high (>5) - Group A, medium (1.5-5) - Group B, and low (<1.5) – Group C.  
The fourth group (D) consisted of countries with high rates of gastric cancer (>15) and low 
EAC (<1.5).   
     The countries in these different groupings are shown in Figure 2.  Group A with the 
highest rate of EAC and low (<15) TGC was limited to the UK, the Netherlands and Ireland.  
Group B with moderate EAC and low TGC (<15) comprised Northern America, Australia, 
New Zealand, Germany, Belgium, Denmark, Finland, Norway, France, Brazil and Uruguay.  
Area C with low EAC and low TGC (<15) was a very heterogeneous group from around the 
world  (Thailand, Phiippines, India, Bulgaria, Croatia, Egypt, Israel, Italy, Spain, Poland, 
Serbia, Slovakia, Singapore);   Group D with low EAC and moderate to high TGC includes 
South American countries, Eastern Europe, Korea, China, Japan, Russia, Iran and Turkey.  
     In women, sub-dividing all countries into groups based on their rates of esophageal and 
gastric cancer incidence demonstrated similar geographical patterns (Fig S2 in supplement). 
 
 
B. Longitudinal Study 
 
   B1.  Changes in incidence of esophageal adenocarcinoma and gastric cancer 
 
     To explore the rate of change in incidence of EAC and TGC during the period of 1989- 
2007 in males, we calculated average annual percentage change (AAPC) for each of the 38 
populations individually, and presented these in Fig. 3, ordered by the most recent incidence 
of EAC. During this time period, most populations (34/38, 89%) had experienced a 
significant decrease in the incidence of TGC, with these 34 showing a range of AAPC from -
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1.4% (95% CI: -2.1, -0.6 in Japan, Miyagi) to -5.1% (95% CI: -5.8, -4.3) in Austria, Tyrol.    
Twenty-five of 38 (66%) populations showed a significant increase in incidence of EAC 
during the period of observation and no population showed a significant fall in incidence (Fig. 
3).  Annual increases in EAC incidence ranged from 1.5% (95% CI: 0.8, 2.3 in Victoria, 
Australia) to 11.7% (95% CI: 3.7, 20.2 in Estonia).  
     We investigated any differences between the 13 populations showing no significant rise 
in EAC and the 25 population showing a rise.  The populations which showed no significant 
change in EAC showed a rate of decrease in TGC (AAPC range -4.9% to 0.7%) similar to 
those that showed increase in EAC (AAPC range = -5.1% to -1.4%), (p=0.504).  Likewise, 
the registries showing no rise in EAC did not differ from those showing an increase in that 
the two groups had a similar most recent (2007) TGC incidence (9.5 vs 9.6/1000,000py; 
p=0.584).     
     The data for women again showed a similar pattern and are shown in Fig S3.   
Additionally, further analyses using longer but varying periods of observation (19-50 years) 
were conducted with similar findings and are presented in the supplement as Fig S4 for men 
only.   
 
   B2.  Correlation of Incidence trends of EAC and TGC 
 
     We looked for any correlation between the incidence trends for both cancers for those 38 
populations with sufficient longitudinal data and included the full observation period of paired 
data (ie not limited to 1989-2007) (Table 3).  In men, significant negative correlations 
between incidence rate trends of EAC and TGC over time were present in 27 of the 38 
populations when compared over preceding 19-50 years and evaluated in pairs (Table 3). 
Positive correlations were not observed for any population.   
     When the calculation of correlations between EAC and TGC incidence trends was limited 
to the common but shorter observation period (last 19 years of 1989-2007), the magnitude of 
correlations was weaker in some of the populations.  Only 19 of 38 populations showed 
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significant negative correlations for men and 7 of 38 for women (see Table S2 in 
supplement).   
 
C.  Relationship of longitudinal and cross-sectional data 
     We investigated the relationship between the cross-sectional data of most recent 
incidences of the two cancers and the longitudinal incidence trends.  On the cross-sectional 
scatter plot figure showing the correlation between current incidence of EAC and TGC 
across different countries we superimposed a line indicating the incidence trend over 
preceding years available from the longitudinal data.   This allowed us to examine the 
changes in incidence of both TGC and EAC cancer over time and how it related to their 
current incidences in different countries.  To facilitate visual inspection we did this separately 
for each of the four categories of countries i.e. groups A,B,C and D based on incidence 
pattern of the two cancers (Fig. 4).   For the longitudinal data we selected the 3 populations 
from each of groups A, B, C and D with the longest observation periods. 
     The resulting plots indicated that the countries with current low incidence of TGC and 
current high, medium or low incidence of EAC had previously resembled countries with a 
current high incidence of TGC and current low incidence of EAC.  As the incidence of TGC 
has fallen this has been accompanied by varying degrees of increase in EAC with some 
populations showing a marked increase, some moderate increase and some no increase. 
 
DISCUSSION 
 
     Our study has demonstrated an inverse association between the incidence of EAC and 
gastric cancer.  This is apparent with respect to both the current incidences of these two 
cancers across different countries and with respect to changing incidence of the two cancers 
within the same populations over time.  The inverse association is intriguing in view of the 
fact that the two cancers are biologically very similar.  Both EAC and TGC arise from 
epithelia of closely adjacent, indeed abutting regions of the upper gastrointestinal tract, both 
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are the result of chronic damage and inflammation exerted by their luminal environment and 
both usually show very similar and often indistinguishable histological appearance.  
     Our cross-sectional study showed that both cancers were similar in having a wide range 
in current incidence rates (20-30 fold in males) across the different countries but different in 
having contrasting geographical patterns. The longitudinal studies showed that the 
incidences of both TGC and EAC had changed markedly over recent decades but these 
changes were in opposite directions and there was a statistically significant inverse 
association between the changing incidence rates of the two cancers in 71% of the 
registries.   
     Combining the cross-sectional and longitudinal data provided an overall picture of what 
has been happening to these two cancers over time and in different regions of the world.  
Previously, most countries had a high incidence of gastric cancer and a low incidence of 
EAC.  Since then, the incidence of gastric cancer has fallen in all countries and as it has 
reached low levels it has been accompanied by varying degrees of increase in EAC with 
some regions showing marked increase, some moderate and others no increase. 
     What is the explanation for the opposing incidences and time trends of these two 
cancers?  Could differences between countries in classification of junctional cancers into 
esophageal versus gastric locations and/or changes in classification of these cancers over 
time explain some of the observations?  In the cross-sectional study, we found that the 
inverse association remained strong and indeed became slightly stronger by excluding 
cancers occurring at the gastric cardia and thus more likely to be misclassified.  The 
longitudinal data only provided information on TGC. Spurious inverse association between 
incidence trends of the two cancers due to changing classification of cardia junctional 
cancers would only be likely to be a significant issue in countries with a very high incidence 
of gastric cancer and low incidence of EAC as misclassification of a small proportion of the 
former could substantially increase the latter21.  Such misclassification, however, could not 
explain the strong inverse incidence trends as they were most apparent in countries with 
lower gastric cancer incidence 22.   
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     The marked changes in incidence of TGC and EAC over a short time scale indicate the 
influence of a changing environmental factor.  In addition, the inverse association between 
the changing incidences indicates that the environment factor is exerting opposite effects on 
these two cancers.  The environmental factors which are thought to explain the falling 
incidence of TGC include a falling incidence of H. pylori atrophic gastritis, dietary changes 
and reduced smoking (23,24).  Could the falling incidence of any of these be associated with 
an increase in EAC and thus explain the inverse association in the incidence trends of the 
two cancers?  Smoking is not a candidate as it is a similar risk factor for both cancers (5,25).  
Dietary changes might be important.  There is some evidence that increased intake of 
vitamins and reduced salt consumption may have contributed to the falling incidence of 
gastric cancer (26,27).  These specific dietary factors would not in themselves explain the 
increase in EAC and indeed increased vitamin consumption may protect from EAC (28).  
However, increased caloric intake and associated obesity is a well-established risk factor for 
EAC (28).  It is therefore possible that changes in the diet comprising both a fall in salt content 
and increased caloric content could produce a fall in total TGC and rise in EAC.  However, a 
recent analysis indicated that increasing obesity may only account for 6.5% of the increase 
in incidence of EAC and suggesting the role of additional environmental factors (3).   
     Another environmental factor which might exert opposite effects on the incidence of the 
two cancers is H. pylori atrophic gastritis which is the most important etiological factor for 
NCGC (29).  In countries with a high incidence of gastric cancer there is also a high incidence 
of atrophic gastritis and associated impaired gastric acid secretion (30).  In contrast, in 
subjects without H.pylori, gastric acid is maintained and shows no decline with increasing 
age(31).  In countries with a high incidence of gastric cancer the high prevalence of H.pylori 
atrophic gastritis will protect from EAC as any gastroesophageal refluxate will have reduced 
ability to damage the esophagus due to its reduced acidity.  Epidemiological studies have 
shown consistent associations between H. pylori and both TGC and EAC being positive with 
respect to the former and negative with respect to the latter (10).   As the prevalence of 
H.pylori atrophic gastritis falls, it will be accompanied by a fall in gastric cancer but 
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potentially also a rise in EAC due to increasing gastric acidity.  The prevalence of H. pylori 
infection has fallen over recent decades in association with improved living conditions (32).   
     Interactions between H. pylori and dietary factors might also be important.   There is 
some evidence that a high vitamin, low salt diet may protect from the development of 
atrophic gastritis in H. pylori infected subjects (33).  Improved living conditions, with 
accompanying fall in H. pylori prevalence as well as increased vitamin and reduced salt 
intake could together markedly reduce atrophic gastritis with resultant fall in TGC and 
increase in EAC. 
     In the previous study by Anderson et al showing a strong negative association between 
H.pylori and esophageal adenocarcinoma, the association persisted even after correcting for 
atrophic gastritis detected by serum pepsinogens (8).  However, it is recognised that serum 
pepsinogens are insensitive markers of atrophy(34).  In addition, H.pylori body-predominant 
gastritis is associated with reduced gastric acid secretion independent of atrophy.(35)   
Furthermore, body-predominant gastritis is an important risk factor for gastric cancer(36) so 
even without significant atrophy it might both promote gastric cancer and protect from 
esophageal adenocarcinoma. 
     Though there were strong inverse associations between the two cancers with respect to 
both current incidences and time trends, there was a group of countries with a low incidence 
of both cancers.  This was a heterogeneous group consisting of Thailand, Philippines, 
Singapore, India, Egypt, Israel, Bulgaria, Croatia, Italy, Spain, Poland, Serbia and Slovenia.  
Due to the limited availability of longitudinal data for many of these populations, it was 
difficult to determine whether their low incidence of both cancers was due to the absence of 
a rise in EAC as their incidence of TGC fell, or whether they had never had a high incidence 
of TGC and were somehow protected from both cancers.  It is possible that genetic and/or 
environmental factors present in some of these populations might inhibit the progression 
from inflammation to neoplasia which is a common final step in the pathways leading to both 
TGC and EAC.  A lack of increase in EAC despite TGC falling to a low level might be due to 
genetic and/or environmental factors protecting from gastroesophageal reflux which is an 
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essential early step in the pathway to EAC.  Comparative studies of countries with low 
versus high incidence of EAC despite low incidence of TGC may shed new light on the 
etiology and pathogenesis of EAC. 
    An important question is whether countries where gastric cancer incidence is still high but 
falling such as Japan and South East Asia will encounter a rise in EAC similar to that 
recently experienced in Western countries.  A fall in the incidence of gastric cancer to a low 
level is not necessarily accompanied by a rise in esophageal adenocarcinoma as highlighted 
above.  However, the current incidence of gastric cancer in Japan and South East Asia is 
still at a level which when present in Western countries was not yet associated with any rise 
in EAC and it will be interesting to observe what happens when this point is reached. 
     Strengths of our study include the use of high quality global surveillance data. Limitations 
also need however to be recognised.  Incidence rates used in the cross-sectional analysis 
were based on country-, age- and sex-specific proportions of EAC from CI5X, which were 
then applied to GLOBOCAN 2012 data.  Hence, they represent estimates of the true 
incidence rates within each country and should be interpreted with caution.  Our inclusion 
criteria for the cross-sectional study furthermore resulted in a selection of 51 mostly high-
income countries, which may not be fully representative on the global level.  Pathological 
practices and classifications of histological subtypes have changed over time, which should 
be kept in mind when interpreting the results, especially from the longitudinal analyses.  
Also, registries covering different time periods (19 to 50 years) were included in some of the 
longitudinal analysis, making them not directly comparable.   Finally, most of the countries 
included in the cross-sectional studies have more than one original cancer registry and even 
though we selected the largest registry available from each country, it may not represent the 
full national picture.   
   In conclusion, this study demonstrates a strong inverse association between gastric cancer 
and EAC with respect to both their current incidences and time trends, suggesting a 
changing common environmental influence exerting opposite effects on these two cancers.  
Though ecological studies do not establish causality, one biologically plausible 
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environmental factor which could explain this unusual inverse association is H. pylori 
atrophic gastritis.  However, changes in disease incidence are usually the result of several 
interacting environmental factors and changes in lifestyle predisposing to obesity as well as 
dietary interactions with H. pylori  to induce atrophy are also likely to be important.  
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FIGURE LEGENDS 
 
 
Fig 1: Correlations between incidence rates (WASR) of EAC and gastric cancer in cross-
sectional study in men.   
Note: Each dot represents a dataset from a country, 1a: EAC versus total gastric cancer, 1b. 
EAC versus non-cardia gastric cancers, 1c: visual clustering of countries divided into groups 
A-D. 
 
Fig 2: Maps of countries colour-coded with visual clustering of populations with different 
combinations of EAC and gastric cancer in cross-sectional study in men.  
Note: For each country, a pooled national data has been used to create colour codes. The 
grey code indicates no data available. A: TGC<15 & EAC≥5,   B: TGC<15 & 1.5≤EAC<5,   
C: TGC<15 & EAC<1.5,   D: TGC≥15 & EAC<1.5. 
 
Fig 3: Average Annual Percentage Changes (95% CI) of EAC versus TGC in men during 
short common period (1989-2007) of registration in populations. 
 
 
Fig 4: Longitudinal data superimposed on cross-sectional cancer incidence by groups A-D in 
men. 
Incidence of esophageal adenocarcinoma is shown on Y axis (per 100,000py) and incidence 
of total gastric cancer on X axis. The cross-sectional data of the most recent cancer 
incidence for different countries is shown by dots.  For the three populations with the longest 
available longitudinal data, we have superimposed on the dot diagram a line indicating their 
incidence trend from start to end of registration period dates.  The dates of the start and end 
of the incidence trend line is given above in box and the time-line is always from right to left.   
 
 
 
Supplementary figures 
 
Fig S1: Correlations between incidence rates (WASR) of EAC and gastric cancer in cross-
sectional study in women. 
Note: each dot represents a dataset from a country, 1a: EAC versus total gastric cancer, 1b. 
EAC versus non-cardia and other gastric cancers, 1c: visual clustering of countries divided 
into groups A-D. 
 
 
Fig S2: Maps of countries colour-coded with visual clustering of populations with different 
combinations of EAC and gastric cancer in cross-sectional study in females.   
Note: For each country, a pooled national data has been used to create colour codes. The 
grey code indicates no data available. A: TGC<7.5 & EAC≥1,   B: TGC<7.5 & 0.3≤EAC<1,   
C: TGC<7.5 & EAC<0.3,   D: TGC≥7.5 & EAC<0.3. 
 
Fig S3: Average Annual Percentage Changes (AAPC) of EAC versus TGC in women during 
short common period (1989-2007) of registration. 
 
Fig S4: Average Annual Percentage Changes (AAPC) of EAC versus TGC in men during full 
period (19-50 years) of registration. 
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Table 1: Estimated age-standardised incidence rates (world) of gastric cancer and esophageal adenocarcinoma 
in different countries in cross-sectional study. The countries are listed based on incidence of Esophageal 
adenocarcinoma. 
 Men 
 
Women 
Country TGC Cardia NCGC EAC 
 
TGC Cardia NCGC EAC 
United Kingdom 6.44 3.89 2.55 7.24  3.15 1.46 1.69 1.36 
The Netherlands 7.61 3.39 4.22 7.05  3.9 1.03 2.86 1.19 
Ireland 8.83 3.64 5.19 5.36  4.42 1.42 3 1.01 
New Zealand 6.69 3.27 3.42 3.96  3.83 0.88 2.94 0.56 
United States of America 5.33 2.6 2.73 3.62  2.7 0.66 2.04 0.42 
Belgium 8.04 4.96 3.08 3.53  3.83 1.36 2.48 0.57 
Australia 6.72 3.44 3.27 3.41  3.14 0.99 2.15 0.49 
Denmark 8.32 5.79 2.53 3.07  3.05 1.27 1.78 0.76 
Canada 6.95 3.26 3.69 2.99  3.12 0.83 2.29 0.42 
Switzerland 5.01 2.21 2.8 2.59  3.58 0.89 2.69 0.49 
Norway 5.61 2.41 3.2 2.32  3.82 0.91 2.91 0.43 
Malta 11.08 6.1 4.98 2.3  5.53 1.2 4.33 0.11 
Germany 10.66 3.84 6.82 2.16  5.44 1.01 4.43 0.28 
Czech Republic 10.21 2.81 7.41 2.16  5.27 0.75 4.52 0.29 
Uruguay 14.36 7.61 6.75 2.07  6.7 2.06 4.64 0.61 
Argentina 9.87 2.79 7.08 1.98  4.19 0.71 3.48 0.44 
Austria 9.2 4.89 4.31 1.97  4.83 1.42 3.41 0.23 
Brazil 13.08 4.26 8.82 1.96  5.96 1.16 4.8 0.59 
Finland 6.72 4.86 1.86 1.8  3.94 2.06 1.88 0.3 
France (metropolitan) 6.97 3.03 3.94 1.56  2.8 0.48 2.32 0.33 
Spain 10.97 2.91 8.05 1.27  5.11 0.66 4.45 0.18 
Colombia 18.89 6.93 11.95 1.11  8.97 2.18 6.8 0.21 
Lithuania 22.73 2.99 19.75 1.09  8.02 0.61 7.41 0.15 
Turkey 17.92 4.49 13.43 1.09  10.93 2.34 8.59 0.21 
Israel 9.71 4.03 5.68 0.94  4.9 1.45 3.45 0.2 
Puerto Rico 5.28 1.37 3.91 0.94  3.11 0.48 2.64 0.26 
Ukraine 22.39 4.36 18.03 0.9  9.14 1.29 7.85 0.16 
Latvia 23.05 4.97 18.08 0.86  8.68 0.93 7.74 0.18 
Bulgaria 14.51 2.71 11.8 0.86  6.99 0.88 6.12 0.12 
Croatia 14.47 7.5 6.97 0.85  6.27 2.39 3.88 0.12 
Iran, Islamic Republic of 20.6 13.37 7.22 0.85  9.72 5.4 4.32 0.85 
Belarus 29.14 3.37 25.77 0.84  12.22 0.95 11.27 0.1 
China 32.77 11.97 20.8 0.83  13.1 3.37 9.73 0.26 
Russian Federation 24.45 4.74 19.71 0.79  10.8 1.58 9.21 0.13 
Slovakia 13.95 3.43 10.52 0.79  6.58 0.92 5.66 0.15 
Costa Rica 21.43 4.65 16.78 0.75  13.66 1.48 12.18 0.15 
Chile 23.29 7.35 15.94 0.74  9.19 1.99 7.2 0.26 
Slovenia 15.37 5.01 10.36 0.65  6.42 1.02 5.4 0.1 
Italy 10.89 2.43 8.46 0.61  5.92 0.63 5.29 0.09 
Serbia 11.94 6.69 5.25 0.59  5.68 2.94 2.75 0.14 
Philippines 4.81 2.03 2.78 0.56  2.88 0.89 1.99 0.14 
Egypt 2.84 1.09 1.75 0.52  2.27 0.55 1.72 0.28 
Poland 13.19 7.87 5.32 0.5  4.95 2.08 2.86 0.09 
Estonia 19.5 2.96 16.54 0.44  10.31 1.03 9.28 0.07 
India 8.56 3.26 5.3 0.43  3.68 1.41 2.27 0.13 
Japan 45.75 4.73 41.01 0.42  16.46 1.25 15.21 0.07 
Saudi Arabia 3.84 1.36 2.48 0.42  2.41 0.72 1.69 0.15 
Singapore 10.85 3.18 7.67 0.34  5.83 1.31 4.52 0.07 
Ecuador 20.69 3.5 17.19 0.33  13.43 0.95 12.48 0.21 
Thailand 3.77 1.36 2.41 0.27  2.49 0.8 1.68 0.08 
Korea, Republic of 62.26 3.62 58.64 0.23  24.67 1.07 23.6 0.04 
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Table 2: List of recruited registries in longitudinal study, and incidence rates (WASR) of total gastric cancer and esophageal adenocarcinoma at the start, 
year 1989 and end of period 
Study Population 
 
Full-range 
Period (yrs) 
Men  Women 
EAC 
(start) 
EAC 
(1989) 
EAC 
(2007) 
TGC 
(start) 
TGC 
(1989) 
TGC 
(2007) 
 EAC 
(start) 
EAC 
(1989) 
EAC 
(2007) 
TGC 
(start) 
TGC 
(1989) 
TGC 
(2007) 
Brazil, Goiania 1988 -2007  (20) 0.45 0.45 0.51 25.46 25.46 25.86  0.01 0.06 0.06 52.05 30.70 17.26 
Estonia, all 1968 -2007  (40) 0.04 0.09 0.56 57.27 35.25 23.29  0.16 0.03 0.06 8.62 6.67 4.30 
Thailand, Chiang Mai    1983 -2007  (25) 0.00 0.06 0.11 8.25 8.09 6.84  0.08 0.05 0.02 5.10 4.08 2.58 
Switzerland, St Gall-Appenzell 1983 -2007  (25) 0.93 0.76 3.22 12.09 12.23 6.41  0.32 0.35 0.53 6.14 5.32 3.92 
Israel, Jews 1963 -2007  (45) 0.06 0.08 0.86 24.84 13.26 9.58  0.00 0.05 0.17 8.63 7.96 7.01 
Croatia, all 1988 -2007  (20) 0.26 0.26 0.63 28.98 28.98 17.36  0.02 0.04 0.09 19.41 10.89 7.19 
Spain, Murcia 1983 -2007  (25) 0.74 1.21 1.44 17.88 15.67 10.46  0.09 0.02 0.24 5.96 5.02 3.31 
Austria, Tyrol                1988 -2007  (20) 0.42 0.42 0.79 28.24 28.24 11.24  0.04 0.09 0.16 6.69 6.22 4.78 
France, Bas-Rhin 1975 -2007  (33) 0.88 0.83 2.12 17.58 12.78 8.42  0.00 0.11 0.35 8.14 7.27 4.33 
Spain, Granada 1985 -2007  (23) 0.58 0.39 1.16 17.77 14.92 10.02  0.03 0.03 0.22 16.40 16.40 6.93 
Netherlands, all 1989 -2007  (19) 2.26 2.26 5.42 15.68 15.68 8.88  0.58 0.58 0.93 6.11 6.11 3.98 
USA, Michigan, Detroit, Whites 1973 -2007  (35) 0.67 1.74 4.39 10.13 9.56 6.42  0.10 0.22 0.64 4.49 3.76 2.93 
Switzerland, Vaud 1988 -2007  (20) 1.48 1.48 2.47 10.63 10.63 7.22  0.13 0.13 0.36 11.3 4.88 3.22 
USA, Michigan, Detroit, Blacks   1973 -2007  (35) 0.30 0.48 1.03 16.24 16.10 12.08  0.04 0.05 0.19 14.78 6.19 5.20 
Canada, Manitoba 1958 -2007  (50) 0.08 1.28 2.64 25.6 12.60 8.33  0.05 0.26 0.42 4.45 3.28 2.26 
England, North West 1979 -2007  (29) 1.58 3.70 7.07 22.32 17.76 10.12  0.46 0.86 1.34 10.01 7.74 4.08 
USA, SEER (9 Regs), Whites 1975 -2007  (33) 0.61 1.83 3.74 9.31 8.04 5.55  0.22 0.27 0.60 7.02 5.09 3.35 
Scotland, all 1975 -2007  (33) 2.36 3.42 7.47 21.17 18.56 9.72  0.83 1.05 1.49 10.64 7.90 4.57 
Australia, New South Wales 1983 -2007  (25) 0.71 1.54 2.67 12.36 10.82 7.54  0.00 0.26 0.50 8.03 6.46 3.68 
Canada, Saskatchewan 1968 -2007  (40) 0.13 1.20 1.99 14.2 8.51 5.93  0.00 0.00 0.31 18.15 19.07 13.53 
USA, Calif, Los Angel, Non-His Whites 1973 -2007  (35) 0.35 1.61 2.77 9.92 7.99 5.52  0.10 0.22 0.51 4.03 3.19 2.43 
Japan, Osaka 1963 -2007  (45) 0.00 0.22 0.41 107.06 70.42 44.19  0.15 0.25 0.03 23.39 17.19 14.11 
England, South & West 1979 -2007  (29) 1.40 3.46 5.84 17.21 14.79 7.02  0.30 0.48 1.11 6.99 3.77 2.72 
Japan, Miyagi 1978 -2007  (30) 0.68 0.43 0.69 82.51 84.41 65.72  0.05 0.19 0.10 8.44 7.09 5.20 
Slovakia, all                   1973 -2007  (35) 0.15 0.35 0.78 42.30 25.06 16.43  0.00 0.04 0.15 8.29 5.40 3.80 
India, Mumbai               1978 -2007  (30) 0.29 0.04 0.08 7.11 6.68 4.46  0.11 0.11 0.00 12.46 12.46 12.27 
USA, SEER (9 Regs), Blacks       1975 -2007  (33) 0.17 0.46 0.74 15.30 15.04 10.43  0.00 0.00 0.14 23.97 23.97 10.48 
Australia. Victoria 1983 -2007  (25) 1.23 1.74 2.64 14.84 12.33 7.97  0.12 0.20 0.45 5.27 4.40 3.47 
Colombia, Cali 1983 -2007  (25) 0.19 0.68 0.87 32.46 33.40 25.82  0.00 0.07 0.18 7.82 6.31 4.81 
Italy, Romagna 1988 -2007  (20) 0.44 0.44 0.45 41.78 41.78 20.34  0.23 0.05 0.03 38.26 34.52 22.21 
Singapore, Chinese 1968 -2007  (40) 0.00 0.28 0.38 45.07 33.48 14.90  0.00 0.00 0.03 4.48 4.79 4.17 
Denmark, all 1978 -2007  (30) 0.81 1.76 2.54 15.05 10.29 7.68  0.19 0.19 0.40 3.88 3.88 3.86 
Philippines, Manila      1983 -2007  (25) 0.32 0.34 0.45 14.16 11.72 6.91  0.00 0.02 0.04 17.21 15.12 7.86 
Italy, Torino 1985 -2007  (23) 0.41 0.55 0.82 20.25 19.18 10.65  0.00 0.00 0.16 8.94 9.15 5.40 
Costa Rica, all 1980 -2007  (28) 0.55 0.52 0.63 48.40 39.53 24.65  0.08 0.08 0.08 11.87 11.87 7.22 
USA, Calif, Los Angel, Blacks    1973 -2007  (35) 0.37 0.68 0.59 15.53 13.76 8.66  0.00 0.05 0.08 26.73 16.45 11.43 
France, Isere 1979 -2007  (29) 0.33 1.98 1.51 13.26 14.81 7.36  0.04 0.05 0.28 6.81 3.54 3.01 
USA, Calif, Los Angel, His Whites 1973 -2007  (35) 0.04 1.47 1.47 14.98 13.43 9.53  0.09 0.14 0.27 7.68 5.77 5.62 
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Table 3: Correlations between incidence (WASR) trends of esophageal adenocarcinoma and total gastric cancer  
In men in the two time periods- full range and 1989-2007. 
Study Population 
 
Population Full Range  1989 - 2007 
(2007) Period (yrs) CC P value  CC P value 
Brazil, Goiania 588132 1988 -2007  (20) 0.048 0.84  0.098 0.70 
Estonia, all 617828 1968 -2007  (40) -0.420 0.01  -0.471 0.04 
Thailand, Chiang Mai 741784 1983 -2007  (25) -0.281 0.17  -0.109 0.66 
Switzerland, St Gall-Appenzell 263298 1983 -2007  (25) -0.590 0.00  -0.519 0.02 
Israel, Jews 2674800 1963 -2007  (45) -0.637 0.00  -0.173 0.48 
Croatia, all 2137984 1988 -2007  (20) -0.737 0.00  -0.713 0.00 
Spain, Murcia 714667 1983 -2007  (25) -0.394 0.05  -0.382 0.11 
Austria, Tyrol 342794 1988 -2007  (20) -0.530 0.02  -0.475 0.04 
France, Bas-Rhin 534515 1975 -2007  (33) -0.536 0.00  -0.458 <0.05 
Spain, Granada 438332 1985 -2007  (23) -0.442 0.04  -0.396 0.09 
Netherlands, all 8100293 1989 -2007  (19) -0.961 0.00  -0.971 0.00 
USA, Michigan, Detroit, Whites 1390555 1973 -2007  (35) -0.921 0.00  -0.821 0.00 
Switzerland, Vaud 323759 1988 -2007  (20) -0.402 0.08  -0.370 0.12 
USA, Michigan, Detroit, Blacks 475552 1973 -2007  (35) -0.271 0.12  0.193 0.43 
Canada, Manitoba 588875 1958 -2007  (50) -0.777 0.00  -0.402 0.09 
England, North West 3223560 1979 -2007  (29) -0.926 0.00  -0.800 0.00 
USA, SEER (9 Regs), Whites 10682176 1975 -2007  (33) -0.972 0.00  -0.834 0.00 
Scotland, all 2485606 1975 -2007  (33) -0.961 0.00  -0.913 0.00 
Australia, New South Wales 3420484 1983 -2007  (25) -0.888 0.00  -0.810 0.00 
Canada, Saskatchewan 495639 1968 -2007  (40) -0.724 0.00  -0.083 0.73 
USA, Calif, Los Angel, Non-His Whites 1446148 1973 -2007  (35) -0.843 0.00  -0.520 0.02 
Japan, Osaka 4366616 1963 -2007  (45) -0.915 0.00  -0.572 0.01 
England, South & West 3442830 1979 -2007  (29) -0.924 0.00  -0.774 0.00 
Japan, Miyagi 1140676 1978 -2007  (30) -0.383 0.04  -0.574 0.01 
Slovakia, all 2621095 1973 -2007  (35) -0.818 0.00  -0.463 <0.05 
India, Mumbai 7479777 1978 -2007  (30) -0.425 0.02  -0.567 0.01 
USA, SEER (9 Regs), Blacks 1724091 1975 -2007  (33) -0.592 0.00  -0.434 0.06 
Australia. Victoria 2574901 1983 -2007  (25) -0.810 0.00  -0.593 0.01 
Colombia, Cali 1000036 1983 -2007  (25) 0.010 0.96  0.029 0.91 
Italy, Romagna 577247 1988 -2007  (20) -0.074 0.76  -0.192 0.43 
Singapore, Chinese 1324700 1968 -2007  (40) -0.558 0.00  -0.188 0.44 
Denmark, all 2704655 1978 -2007  (30) -0.930 0.00  -0.766 0.00 
Philippines, Manila 2993487 1983 -2007  (25) -0.371 0.07  -0.185 0.45 
Italy, Torino 435148 1985 -2007  (23) -0.341 0.11  0.048 0.84 
Costa Rica, all 2227538 1980 -2007  (28) -0.008 0.97  -0.419 0.07 
USA, Calif, Los Angel, Blacks 450132 1973 -2007  (35) -0.357 0.04  -0.155 0.53 
France, Isere 585746 1979 -2007  (29) 0.045 0.82  0.129 0.60 
USA, Calif, Los Angel, His Whites 2220592 1973 -2007  (35) -0.457 0.01  -0.076 0.76 
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ABSTRACT 
  
 
Objectives:     The incidence of esophageal adenocarcinoma (EAC) is increasing while 
adenocarcinoma of the stomach is decreasing.  We have investigated whether the 
incidences of these two cancers and their time trends might be inversely related pointing to a 
common environmental factor exerting opposite effects on these cancers. 
 
Methods: For cross-sectional analyses data were abstracted from “Cancer Incidence in Five 
Continents” (CI5) Volume X and GLOBOCAN 2012.  Relevant ICD-10 codes were used to 
locate esophageal and gastric cancers anatomically, and ICD-O codes for the histological 
diagnosis of EAC.  For longitudinal analyses age standardised rates (ASR) of EAC and total 
gastric cancer (TGC) were extracted from CI5C-Plus. 
 
Results: Estimated (2012) ASRs were available for 51 countries and these showed 
significant negative correlations between EAC and both TGC (males: CC=-0.38, p=0.006, 
females: CC=-0.41, p=0.003) and non-cardia gastric cancer rates (males CC= -0.41, 
p=0.003 and females CC=-0.43, p=0.005).  Annual incidence trends were analysed for                       
38 populations through 1989-2007 and showed significant decreases for TGC in 89% and 
increases for EAC in 66% of these, with no population showing a fall in the latter. Significant 
negative correlation between the incidence trends of the two cancers was observed in 28 of 
the 38 populations over the 19-50 years of available paired data.  Super-imposition of the 
longitudinal and cross-sectional data indicated that populations with a current high incidence 
of EAC and low incidence of gastric cancer had previously resembled countries with a high 
incidence of gastric cancer and low incidence of EAC.   
 
Conclusion: The negative association between gastric cancer and EAC in both current 
incidences and time trends is consistent with a common environmental factor predisposing 
to one and protecting from the other.   
 
Key words:  Esophageal adenocarcinoma, Gastric cancer, Incidence, Negative correlation, 
Epidemiology, Atrophic gastritis,  Helicobacter pylori.   
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STUDY HIGHLIGHTS 
 
 
WHAT IS CURRENT KNOWLEDGE 
- The incidence of esophageal adenocarcinoma (EAC) is increasing rapidly in Western 
populations. 
 
- The incidence of gastric cancer is decreasing throughout the world. 
 
 
WHAT IS NEW HERE 
 
- We have demonstrated an inverse relationship between the current incidences of 
those two cancers for countries throughout the world. 
 
- We have demonstrated an inverse relationship between the incidence trends of the 
two cancers within individual cancer registries. 
 
- Countries with a current high incidence of EAC and low incidence of gastric cancer 
previously resembled countries with a current low incidence of EAC and high 
incidence of gastric cancer. 
 
 
- The inverse association between these two cancers is consistent with changes in the 
prevalence of a common environmental factor predisposing to one and protecting 
from the other.  
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INTRODUCTION 
     Over the past three decades, esophageal adenocarcinoma (EAC) has been one of the 
fastest increasing malignancies in many countries1,2.  The cancer is thought to be the result 
of gastroesophageal reflux damaging the distal esophagus and causing columnar 
metaplasia often with intestinal phenotype.  This Barrett’s mucosa has an increased risk of 
progressing to dysplasia and adenocarcinoma. 
     The environmental factors causing the recent marked increase in incidence of EAC are 
unclear.  Central obesity is associated with both reflux and EAC and the increasing 
prevalence of obesity is likely to explain some of the rise in incidence of EAC (3,4).       
Smoking is another well-established risk factor for esophageal adenocarcinoma 5.  However, 
the prevalence of smoking has decreased over more than six decades in most Western 
countries and thus this cannot account for more recent increases in incidence of esophageal 
adenocarcinoma 6.    
     Another possible explanation is that H.pylori infection has been protecting against acid 
reflux, and thus EAC, and this is being lost by the falling incidence of the infection7.  There is 
a well-established negative association between H.pylori infection and both 
gastroesophageal reflux and EAC.8,9    This negative association between H.pylori and EAC 
is independent of the other risk factors of EAC including smoking and BMI10.  A proposed 
mechanism for the protective effect of H.pylori is that the gastritis induced by it may cause 
atrophy and reduced acid secretory capacity of the gastric mucosa.  As the acidity of the 
gastric juice is its main damaging component, reduction of this by H.pylori would protect 
against reflux-induced esophageal damage and associated adenocarcinoma11.   
     H. pylori atrophic gastritis is the major risk factor for non-cardia gastric cancer (NGGC)(12).   
If H.pylori infection does protect against EAC by inducing atrophy and reduced acid secretion, there 
should be a negative association between NCGC and EAC at a population level as the gastric 
mucosal changes predisposing to gastric cancer would be the same as those protecting from EAC.  
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Opposing incidence trends for EAC and NCGC have been reported in a study of the population of the 
East of England 
(13)
. 
     This study examined the relationship between the current incidences of the two cancers 
in different geographical regions of the world.  In addition, we studied the relation between 
changes in incidence of the two cancers over time.   
 
MATERIALS & METHODS 
 
Cross-Sectional Studies    
 
     Based on data from Cancer Incidence in Five Continents Vol. X (CI5X) 14 and 
GLOBOCAN 2012 15, age-specific and age-standardized (world population) incidence rates 
(WASR) were estimated for EAC and gastric cancer by topographical subsite (cardia and 
non-cardia) in 2012. This method has been described in more detail by Arnold et al.16 and 
Colquhoun et al.17  In brief, sex- and age-specific (<65; ≥65 years) proportions of EAC were 
computed for all countries included in CI5X except for those with no cases of EAC in one of 
four substrata (male, female; <65, ≥65 years) (N=51). Similarly, the proportions of cardia 
cancer (C16.0) and NCGC (C16.1-6) cases out of all gastric cancers with known topography 
(C16.0-6) were calculated for each country included in CI5X and stratified by sex and the 
same broad age groups, provided there were two or more cases of cardia cancer (CGC) and 
NCGC within each sex and age group stratification. Where there were multiple datasets 
(from different regional cancer registries within a country), cases and populations were 
pooled to obtain estimated national proportions. The histological types of esophageal cancer 
and the topographical classification of gastric cancers were defined according to the third 
edition of the International Classification of Diseases for Oncology (ICD-O-3) presented in 
Cancer Incidence in Five Continents Vol. IX (CI5IX) 18,19. For this analysis, the national or 
regional proportions of CGC/NCGC and EAC cases determined in the previous steps were 
applied to the 2012 gastric and EAC incidence estimates in GLOBOCAN 2012. Age-
standardized incidence rates were computed using the world standard population (Table 1). 
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Longitudinal Studies 
 
     For the longitudinal study, WASR of EAC and total gastric cancer (TGC) were extracted 
from Cancer Incidence in Five Continents-Plus (CI5-plus) 1.  Cardia and non-cardia subsite 
data were not used because there were few longitudinal data for the specific subsite and 
also because there have been continuous changes in the subsite assignation practices for 
gastric cancer in histopathology laboratories.  A total of 38 populations around the world 
were selected for this study based on a) availability of data of esophageal cancer recorded 
by histology, b) a time period of at least 19 years ending in 2007, c) if separate datasets 
were available for ethnic groups, at least one dataset per ethnic group was selected. The 
incidence (WASR) of EAC and TGC at the start year (different for each registry), year 1989 
(earliest time common for all populations) and year 2007 (end year) were reported in Table 
2, for men and women separately. 
 
Statistical Analyses 
 
     For the cross-sectional study, Spearman’s rho correlations were used to explore the 
relationship between WASR of the two cancers. In the longitudinal study, in addition to 
Spearman’s rho correlations for pairwise correlation of EAC and TGC, time trends for 
individual registries, regression modelling was used to estimate the degree of incidence 
changes over time as described by Kim et al 20.  Briefly, using Joinpoint Programme version 
4.1.0 (National Cancer Institute, USA) we analysed the time trend data for each cancer, in 
each registry, in men and women individually (38 x2 x2= 152 datasets). The programme 
fitted the simplest Joinpoint model that the data allowed. The models used the log of the 
WASR for calculating the average annual percent change (AAPC) in rates and their 
corresponding 95% confidence intervals.  When any comparisons were made between 
different populations, the AAPC was always limited to the same 19 year period (1989-2007).  
When correlations were made between the change of cancer incidence between the two 
cancers within the same population, we present this in two different forms, firstly for the full 
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length of available longitudinal data for each population and secondly, limiting it to the same 
common observation period (1989-2007). 
     As EAC is much more common in men, we have focused mainly on results for men within 
the main text but have provided comparable analyses for women in the supplement. 
 
RESULTS 
 
A. Cross-sectional Study of National data     
 
     Incidence rate estimates were available for 51 countries (Table 1).  There was a wide 
range in the rates of both gastric cancer and EAC across these different countries.  The 
incidence of EAC varied from 0.23 per 100,000 person-years to 7.24.  The incidence of TGC 
varied from 2.84 to 62.26 and that of NCGC from 1.75 to 58.64. In general terms, gastric 
cancer incidence was highest in East Asia and lowest in Western Europe and North America 
whereas EAC showed the opposite trend.  In all 51 countries except the UK, EAC incidence 
rates were lower than the TGC rates and in 43 of 51 countries also lower than the NCGC 
incidence rate.    
          Statistically significant negative correlations between the incidence rates of EAC and 
both TGC {men (CC= -0.38, p=0.006), women (CC= -0.41, p=0.003)} and NCGC incidence 
{men (CC= -0.41, p=0.003) and women (CC= -0.43, p=0.005)} were observed.    
     The wide range in incidence of both EAC and TGC together with their inverse correlation 
resulted in a more than 200-fold range in the ratios of TGC to EAC across the different 
countries (more than 200:1 for the Republic of Korea to less than 1:1 for the UK)   
    Despite the strong negative correlation between the incidence rates of the two cancers, 
inspection of the data points indicated that in two respects the correlation was not linear (Fig. 
1a.b).  Firstly, the incidence of EAC seemed to be at a similar low level for all countries with 
moderate or high gastric cancer incidence and with a progressive rise in incidence at lower 
gastric cancer levels.  The incidence of TGC below which the rise in EAC was apparent was 
approximately 15 per 100,000p/y in men (Fig. 1) and 7.5 per 100,000p/y in women (Fig. 
S1a,b).  Secondly, when the incidence of TGC was low, the level of EAC incidence varied 
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considerably between countries with some showing marked elevation, some moderate and 
some no elevation. The equivalent figures for women showed a similar pattern though this 
was less clear due to much lower incidence rates (see Fig. S1a,b in supplement).   
      In order to investigate further the geographical distribution of the countries according to 
their TGC and EAC incidence rates, we sub-divided them into 4 groups  (Fig. 1c).  In men, 
the first 3 groups consisted of countries with low TGC incidence (<15 per 100,000 p/y) and 
EAC incidence high (>5) - Group A, medium (1.5-5) - Group B, and low (<1.5) – Group C.  
The fourth group (D) consisted of countries with high rates of gastric cancer (>15) and low 
EAC (<1.5).   
     The countries in these different groupings are shown in Figure 2.  Group A with the 
highest rate of EAC and low (<15) TGC was limited to the UK, the Netherlands and Ireland.  
Group B with moderate EAC and low TGC (<15) comprised Northern America, Australia, 
New Zealand, Germany, Belgium, Denmark, Finland, Norway, France, Brazil and Uruguay.  
Area C with low EAC and low TGC (<15) was a very heterogeneous group from around the 
world  (Thailand, Phiippines, India, Bulgaria, Croatia, Egypt, Israel, Italy, Spain, Poland, 
Serbia, Slovakia, Singapore);   Group D with low EAC and moderate to high TGC includes 
South American countries, Eastern Europe, Korea, China, Japan, Russia, Iran and Turkey.  
     In women, sub-dividing all countries into groups based on their rates of esophageal and 
gastric cancer incidence demonstrated similar geographical patterns (Fig S2 in supplement). 
 
 
B. Longitudinal Study 
 
   B1.  Changes in incidence of esophageal adenocarcinoma and gastric cancer 
 
     To explore the rate of change in incidence of EAC and TGC during the period of 1989- 
2007 in males, we calculated average annual percentage change (AAPC) for each of the 38 
populations individually, and presented these in Fig. 3, ordered by the most recent incidence 
of EAC. During this time period, most populations (34/38, 89%) had experienced a 
significant decrease in the incidence of TGC, with these 34 showing a range of AAPC from -
Page 30 of 53
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
American Journal of Gastroenterology
For Peer Review
9 
 
1.4% (95% CI: -2.1, -0.6 in Japan, Miyagi) to -5.1% (95% CI: -5.8, -4.3) in Austria, Tyrol.    
Twenty-five of 38 (66%) populations showed a significant increase in incidence of EAC 
during the period of observation and no population showed a significant fall in incidence (Fig. 
3).  Annual increases in EAC incidence ranged from 1.5% (95% CI: 0.8, 2.3 in Victoria, 
Australia) to 11.7% (95% CI: 3.7, 20.2 in Estonia).  
     We investigated any differences between the 13 populations showing no significant rise 
in EAC and the 25 population showing a rise.  The populations which showed no significant 
change in EAC showed a rate of decrease in TGC (AAPC range -4.9% to 0.7%) similar to 
those that showed increase in EAC (AAPC range = -5.1% to -1.4%), (p=0.504).  Likewise, 
the registries showing no rise in EAC did not differ from those showing an increase in that 
the two groups had a similar most recent (2007) TGC incidence (9.5 vs 9.6/1000,000py; 
p=0.584).     
     The data for women again showed a similar pattern and are shown in Fig S3.   
Additionally, further analyses using longer but varying periods of observation (19-50 years) 
were conducted with similar findings and are presented in the supplement as Fig S4 for men 
only.   
 
   B2.  Correlation of Incidence trends of EAC and TGC 
 
     We looked for any correlation between the incidence trends for both cancers for those 38 
populations with sufficient longitudinal data and included the full observation period of paired 
data (ie not limited to 1989-2007) (Table 3).  In men, significant negative correlations 
between incidence rate trends of EAC and TGC over time were present in 27 of the 38 
populations when compared over preceding 19-50 years and evaluated in pairs (Table 3). 
Positive correlations were not observed for any population.   
     When the calculation of correlations between EAC and TGC incidence trends was limited 
to the common but shorter observation period (last 19 years of 1989-2007), the magnitude of 
correlations was weaker in some of the populations.  Only 19 of 38 populations showed 
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significant negative correlations for men and 7 of 38 for women (see Table S2 in 
supplement).   
 
C.  Relationship of longitudinal and cross-sectional data 
     We investigated the relationship between the cross-sectional data of most recent 
incidences of the two cancers and the longitudinal incidence trends.  On the cross-sectional 
scatter plot figure showing the correlation between current incidence of EAC and TGC 
across different countries we superimposed a line indicating the incidence trend over 
preceding years available from the longitudinal data.   This allowed us to examine the 
changes in incidence of both TGC and EAC cancer over time and how it related to their 
current incidences in different countries.  To facilitate visual inspection we did this separately 
for each of the four categories of countries i.e. groups A,B,C and D based on incidence 
pattern of the two cancers (Fig. 4).   For the longitudinal data we selected the 3 populations 
from each of groups A, B, C and D with the longest observation periods. 
     The resulting plots indicated that the countries with current low incidence of TGC and 
current high, medium or low incidence of EAC had previously resembled countries with a 
current high incidence of TGC and current low incidence of EAC.  As the incidence of TGC 
has fallen this has been accompanied by varying degrees of increase in EAC with some 
populations showing a marked increase, some moderate increase and some no increase. 
 
DISCUSSION 
 
     Our study has demonstrated an inverse association between the incidence of EAC and 
gastric cancer.  This is apparent with respect to both the current incidences of these two 
cancers across different countries and with respect to changing incidence of the two cancers 
within the same populations over time.  The inverse association is intriguing in view of the 
fact that the two cancers are biologically very similar.  Both EAC and TGC arise from 
epithelia of closely adjacent, indeed abutting regions of the upper gastrointestinal tract, both 
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are the result of chronic damage and inflammation exerted by their luminal environment and 
both usually show very similar and often indistinguishable histological appearance.  
     Our cross-sectional study showed that both cancers were similar in having a wide range 
in current incidence rates (20-30 fold in males) across the different countries but different in 
having contrasting geographical patterns. The longitudinal studies showed that the 
incidences of both TGC and EAC had changed markedly over recent decades but these 
changes were in opposite directions and there was a statistically significant inverse 
association between the changing incidence rates of the two cancers in 71% of the 
registries.   
     Combining the cross-sectional and longitudinal data provided an overall picture of what 
has been happening to these two cancers over time and in different regions of the world.  
Previously, most countries had a high incidence of gastric cancer and a low incidence of 
EAC.  Since then, the incidence of gastric cancer has fallen in all countries and as it has 
reached low levels it has been accompanied by varying degrees of increase in EAC with 
some regions showing marked increase, some moderate and others no increase. 
     What is the explanation for the opposing incidences and time trends of these two 
cancers?  Could differences between countries in classification of junctional cancers into 
esophageal versus gastric locations and/or changes in classification of these cancers over 
time explain some of the observations?  In the cross-sectional study, we found that the 
inverse association remained strong and indeed became slightly stronger by excluding 
cancers occurring at the gastric cardia and thus more likely to be misclassified.  The 
longitudinal data only provided information on TGC. Spurious inverse association between 
incidence trends of the two cancers due to changing classification of cardia junctional 
cancers would only be likely to be a significant issue in countries with a very high incidence 
of gastric cancer and low incidence of EAC as misclassification of a small proportion of the 
former could substantially increase the latter21.  Such misclassification, however, could not 
explain the strong inverse incidence trends as they were most apparent in countries with 
lower gastric cancer incidence 22.   
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     The marked changes in incidence of TGC and EAC over a short time scale indicate the 
influence of a changing environmental factor.  In addition, the inverse association between 
the changing incidences indicates that the environment factor is exerting opposite effects on 
these two cancers.  The environmental factors which are thought to explain the falling 
incidence of TGC include a falling incidence of H. pylori atrophic gastritis, dietary changes 
and reduced smoking (23,24).  Could the falling incidence of any of these be associated with 
an increase in EAC and thus explain the inverse association in the incidence trends of the 
two cancers?  Smoking is not a candidate as it is a similar risk factor for both cancers (5,25).  
Dietary changes might be important.  There is some evidence that increased intake of 
vitamins and reduced salt consumption may have contributed to the falling incidence of 
gastric cancer (26,27).  These specific dietary factors would not in themselves explain the 
increase in EAC and indeed increased vitamin consumption may protect from EAC (28).  
However, increased caloric intake and associated obesity is a well-established risk factor for 
EAC (28).  It is therefore possible that changes in the diet comprising both a fall in salt content 
and increased caloric content could produce a fall in total TGC and rise in EAC.  However, a 
recent analysis indicated that increasing obesity may only account for 6.5% of the increase 
in incidence of EAC and suggesting the role of additional environmental factors (3).   
     Another environmental factor which might exert opposite effects on the incidence of the 
two cancers is H. pylori atrophic gastritis which is the most important etiological factor for 
NCGC (29).  In countries with a high incidence of gastric cancer there is also a high incidence 
of atrophic gastritis and associated impaired gastric acid secretion (30).  In contrast, in 
subjects without H.pylori, gastric acid is maintained and shows no decline with increasing 
age(31).  In countries with a high incidence of gastric cancer the high prevalence of H.pylori 
atrophic gastritis will protect from EAC as any gastroesophageal refluxate will have reduced 
ability to damage the esophagus due to its reduced acidity.  Epidemiological studies have 
shown consistent associations between H. pylori and both TGC and EAC being positive with 
respect to the former and negative with respect to the latter (10).   As the prevalence of 
H.pylori atrophic gastritis falls, it will be accompanied by a fall in gastric cancer but 
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potentially also a rise in EAC due to increasing gastric acidity.  The prevalence of H. pylori 
infection has fallen over recent decades in association with improved living conditions (32).   
     Interactions between H. pylori and dietary factors might also be important.   There is 
some evidence that a high vitamin, low salt diet may protect from the development of 
atrophic gastritis in H. pylori infected subjects (33).  Improved living conditions, with 
accompanying fall in H. pylori prevalence as well as increased vitamin and reduced salt 
intake could together markedly reduce atrophic gastritis with resultant fall in TGC and 
increase in EAC. 
     In the previous study by Anderson et al showing a strong negative association between 
H.pylori and esophageal adenocarcinoma, the association persisted even after correcting for 
atrophic gastritis detected by serum pepsinogens (8).  However, it is recognised that serum 
pepsinogens are insensitive markers of atrophy(34).  In addition, H.pylori body-predominant 
gastritis is associated with reduced gastric acid secretion independent of atrophy.(35)   
Furthermore, body-predominant gastritis is an important risk factor for gastric cancer(36) so 
even without significant atrophy it might both promote gastric cancer and protect from 
esophageal adenocarcinoma. 
     Though there were strong inverse associations between the two cancers with respect to 
both current incidences and time trends, there was a group of countries with a low incidence 
of both cancers.  This was a heterogeneous group consisting of Thailand, Philippines, 
Singapore, India, Egypt, Israel, Bulgaria, Croatia, Italy, Spain, Poland, Serbia and Slovenia.  
Due to the limited availability of longitudinal data for many of these populations, it was 
difficult to determine whether their low incidence of both cancers was due to the absence of 
a rise in EAC as their incidence of TGC fell, or whether they had never had a high incidence 
of TGC and were somehow protected from both cancers.  It is possible that genetic and/or 
environmental factors present in some of these populations might inhibit the progression 
from inflammation to neoplasia which is a common final step in the pathways leading to both 
TGC and EAC.  A lack of increase in EAC despite TGC falling to a low level might be due to 
genetic and/or environmental factors protecting from gastroesophageal reflux which is an 
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essential early step in the pathway to EAC.  Comparative studies of countries with low 
versus high incidence of EAC despite low incidence of TGC may shed new light on the 
etiology and pathogenesis of EAC. 
    An important question is whether countries where gastric cancer incidence is still high but 
falling such as Japan and South East Asia will encounter a rise in EAC similar to that 
recently experienced in Western countries.  A fall in the incidence of gastric cancer to a low 
level is not necessarily accompanied by a rise in esophageal adenocarcinoma as highlighted 
above.  However, the current incidence of gastric cancer in Japan and South East Asia is 
still at a level which when present in Western countries was not yet associated with any rise 
in EAC and it will be interesting to observe what happens when this point is reached. 
     Strengths of our study include the use of high quality global surveillance data. Limitations 
also need however to be recognised.  Incidence rates used in the cross-sectional analysis 
were based on country-, age- and sex-specific proportions of EAC from CI5X, which were 
then applied to GLOBOCAN 2012 data.  Hence, they represent estimates of the true 
incidence rates within each country and should be interpreted with caution.  Our inclusion 
criteria for the cross-sectional study furthermore resulted in a selection of 51 mostly high-
income countries, which may not be fully representative on the global level.  Pathological 
practices and classifications of histological subtypes have changed over time, which should 
be kept in mind when interpreting the results, especially from the longitudinal analyses.  
Also, registries covering different time periods (19 to 50 years) were included in some of the 
longitudinal analysis, making them not directly comparable.   Finally, most of the countries 
included in the cross-sectional studies have more than one original cancer registry and even 
though we selected the largest registry available from each country, it may not represent the 
full national picture.   
   In conclusion, this study demonstrates a strong inverse association between gastric cancer 
and EAC with respect to both their current incidences and time trends, suggesting a 
changing common environmental influence exerting opposite effects on these two cancers.  
Though ecological studies do not establish causality, one biologically plausible 
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environmental factor which could explain this unusual inverse association is H. pylori 
atrophic gastritis.  However, changes in disease incidence are usually the result of several 
interacting environmental factors and changes in lifestyle predisposing to obesity as well as 
dietary interactions with H. pylori  to induce atrophy are also likely to be important.  
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FIGURE LEGENDS 
 
 
Fig 1: Correlations between incidence rates (WASR) of EAC and gastric cancer in cross-
sectional study in men.   
Note: Each dot represents a dataset from a country, 1a: EAC versus total gastric cancer, 1b. 
EAC versus non-cardia gastric cancers, 1c: visual clustering of countries divided into groups 
A-D. 
 
Fig 2: Maps of countries colour-coded with visual clustering of populations with different 
combinations of EAC and gastric cancer in cross-sectional study in men.  
Note: For each country, a pooled national data has been used to create colour codes. The 
grey code indicates no data available. A: TGC<15 & EAC≥5,   B: TGC<15 & 1.5≤EAC<5,   
C: TGC<15 & EAC<1.5,   D: TGC≥15 & EAC<1.5. 
 
Fig 3: Average Annual Percentage Changes (95% CI) of EAC versus TGC in men during 
short common period (1989-2007) of registration in populations. 
 
 
Fig 4: Longitudinal data superimposed on cross-sectional cancer incidence by groups A-D in 
men. 
Incidence of esophageal adenocarcinoma is shown on Y axis (per 100,000py) and incidence 
of total gastric cancer on X axis. The cross-sectional data of the most recent cancer 
incidence for different countries is shown by dots.  For the three populations with the longest 
available longitudinal data, we have superimposed on the dot diagram a line indicating their 
incidence trend from start to end of registration period dates.  The dates of the start and end 
of the incidence trend line is given above in box and the time-line is always from right to left.   
 
 
 
Supplementary figures 
 
Fig S1: Correlations between incidence rates (WASR) of EAC and gastric cancer in cross-
sectional study in women. 
Note: each dot represents a dataset from a country, 1a: EAC versus total gastric cancer, 1b. 
EAC versus non-cardia and other gastric cancers, 1c: visual clustering of countries divided 
into groups A-D. 
 
 
Fig S2: Maps of countries colour-coded with visual clustering of populations with different 
combinations of EAC and gastric cancer in cross-sectional study in females.   
Note: For each country, a pooled national data has been used to create colour codes. The 
grey code indicates no data available. A: TGC<7.5 & EAC≥1,   B: TGC<7.5 & 0.3≤EAC<1,   
C: TGC<7.5 & EAC<0.3,   D: TGC≥7.5 & EAC<0.3. 
 
Fig S3: Average Annual Percentage Changes (AAPC) of EAC versus TGC in women during 
short common period (1989-2007) of registration. 
 
Fig S4: Average Annual Percentage Changes (AAPC) of EAC versus TGC in men during full 
period (19-50 years) of registration. 
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Table 1: Estimated age-standardised incidence rates (world) of gastric cancer and esophageal adenocarcinoma 
in different countries in cross-sectional study. The countries are listed based on incidence of Esophageal 
adenocarcinoma. 
 Men 
 
Women 
Country TGC Cardia NCGC EAC 
 
TGC Cardia NCGC EAC 
United Kingdom 6.44 3.89 2.55 7.24  3.15 1.46 1.69 1.36 
The Netherlands 7.61 3.39 4.22 7.05  3.9 1.03 2.86 1.19 
Ireland 8.83 3.64 5.19 5.36  4.42 1.42 3 1.01 
New Zealand 6.69 3.27 3.42 3.96  3.83 0.88 2.94 0.56 
United States of America 5.33 2.6 2.73 3.62  2.7 0.66 2.04 0.42 
Belgium 8.04 4.96 3.08 3.53  3.83 1.36 2.48 0.57 
Australia 6.72 3.44 3.27 3.41  3.14 0.99 2.15 0.49 
Denmark 8.32 5.79 2.53 3.07  3.05 1.27 1.78 0.76 
Canada 6.95 3.26 3.69 2.99  3.12 0.83 2.29 0.42 
Switzerland 5.01 2.21 2.8 2.59  3.58 0.89 2.69 0.49 
Norway 5.61 2.41 3.2 2.32  3.82 0.91 2.91 0.43 
Malta 11.08 6.1 4.98 2.3  5.53 1.2 4.33 0.11 
Germany 10.66 3.84 6.82 2.16  5.44 1.01 4.43 0.28 
Czech Republic 10.21 2.81 7.41 2.16  5.27 0.75 4.52 0.29 
Uruguay 14.36 7.61 6.75 2.07  6.7 2.06 4.64 0.61 
Argentina 9.87 2.79 7.08 1.98  4.19 0.71 3.48 0.44 
Austria 9.2 4.89 4.31 1.97  4.83 1.42 3.41 0.23 
Brazil 13.08 4.26 8.82 1.96  5.96 1.16 4.8 0.59 
Finland 6.72 4.86 1.86 1.8  3.94 2.06 1.88 0.3 
France (metropolitan) 6.97 3.03 3.94 1.56  2.8 0.48 2.32 0.33 
Spain 10.97 2.91 8.05 1.27  5.11 0.66 4.45 0.18 
Colombia 18.89 6.93 11.95 1.11  8.97 2.18 6.8 0.21 
Lithuania 22.73 2.99 19.75 1.09  8.02 0.61 7.41 0.15 
Turkey 17.92 4.49 13.43 1.09  10.93 2.34 8.59 0.21 
Israel 9.71 4.03 5.68 0.94  4.9 1.45 3.45 0.2 
Puerto Rico 5.28 1.37 3.91 0.94  3.11 0.48 2.64 0.26 
Ukraine 22.39 4.36 18.03 0.9  9.14 1.29 7.85 0.16 
Latvia 23.05 4.97 18.08 0.86  8.68 0.93 7.74 0.18 
Bulgaria 14.51 2.71 11.8 0.86  6.99 0.88 6.12 0.12 
Croatia 14.47 7.5 6.97 0.85  6.27 2.39 3.88 0.12 
Iran, Islamic Republic of 20.6 13.37 7.22 0.85  9.72 5.4 4.32 0.85 
Belarus 29.14 3.37 25.77 0.84  12.22 0.95 11.27 0.1 
China 32.77 11.97 20.8 0.83  13.1 3.37 9.73 0.26 
Russian Federation 24.45 4.74 19.71 0.79  10.8 1.58 9.21 0.13 
Slovakia 13.95 3.43 10.52 0.79  6.58 0.92 5.66 0.15 
Costa Rica 21.43 4.65 16.78 0.75  13.66 1.48 12.18 0.15 
Chile 23.29 7.35 15.94 0.74  9.19 1.99 7.2 0.26 
Slovenia 15.37 5.01 10.36 0.65  6.42 1.02 5.4 0.1 
Italy 10.89 2.43 8.46 0.61  5.92 0.63 5.29 0.09 
Serbia 11.94 6.69 5.25 0.59  5.68 2.94 2.75 0.14 
Philippines 4.81 2.03 2.78 0.56  2.88 0.89 1.99 0.14 
Egypt 2.84 1.09 1.75 0.52  2.27 0.55 1.72 0.28 
Poland 13.19 7.87 5.32 0.5  4.95 2.08 2.86 0.09 
Estonia 19.5 2.96 16.54 0.44  10.31 1.03 9.28 0.07 
India 8.56 3.26 5.3 0.43  3.68 1.41 2.27 0.13 
Japan 45.75 4.73 41.01 0.42  16.46 1.25 15.21 0.07 
Saudi Arabia 3.84 1.36 2.48 0.42  2.41 0.72 1.69 0.15 
Singapore 10.85 3.18 7.67 0.34  5.83 1.31 4.52 0.07 
Ecuador 20.69 3.5 17.19 0.33  13.43 0.95 12.48 0.21 
Thailand 3.77 1.36 2.41 0.27  2.49 0.8 1.68 0.08 
Korea, Republic of 62.26 3.62 58.64 0.23  24.67 1.07 23.6 0.04 
Page 42 of 53
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
American Journal of Gastroenterology
For Peer Review
21 
 
Table 2: List of recruited registries in longitudinal study, and incidence rates (WASR) of total gastric cancer and esophageal adenocarcinoma at the start, 
year 1989 and end of period 
Study Population 
 
Full-range 
Period (yrs) 
Men  Women 
EAC 
(start) 
EAC 
(1989) 
EAC 
(2007) 
TGC 
(start) 
TGC 
(1989) 
TGC 
(2007) 
 EAC 
(start) 
EAC 
(1989) 
EAC 
(2007) 
TGC 
(start) 
TGC 
(1989) 
TGC 
(2007) 
Brazil, Goiania 1988 -2007  (20) 0.45 0.45 0.51 25.46 25.46 25.86  0.01 0.06 0.06 52.05 30.70 17.26 
Estonia, all 1968 -2007  (40) 0.04 0.09 0.56 57.27 35.25 23.29  0.16 0.03 0.06 8.62 6.67 4.30 
Thailand, Chiang Mai    1983 -2007  (25) 0.00 0.06 0.11 8.25 8.09 6.84  0.08 0.05 0.02 5.10 4.08 2.58 
Switzerland, St Gall-Appenzell 1983 -2007  (25) 0.93 0.76 3.22 12.09 12.23 6.41  0.32 0.35 0.53 6.14 5.32 3.92 
Israel, Jews 1963 -2007  (45) 0.06 0.08 0.86 24.84 13.26 9.58  0.00 0.05 0.17 8.63 7.96 7.01 
Croatia, all 1988 -2007  (20) 0.26 0.26 0.63 28.98 28.98 17.36  0.02 0.04 0.09 19.41 10.89 7.19 
Spain, Murcia 1983 -2007  (25) 0.74 1.21 1.44 17.88 15.67 10.46  0.09 0.02 0.24 5.96 5.02 3.31 
Austria, Tyrol                1988 -2007  (20) 0.42 0.42 0.79 28.24 28.24 11.24  0.04 0.09 0.16 6.69 6.22 4.78 
France, Bas-Rhin 1975 -2007  (33) 0.88 0.83 2.12 17.58 12.78 8.42  0.00 0.11 0.35 8.14 7.27 4.33 
Spain, Granada 1985 -2007  (23) 0.58 0.39 1.16 17.77 14.92 10.02  0.03 0.03 0.22 16.40 16.40 6.93 
Netherlands, all 1989 -2007  (19) 2.26 2.26 5.42 15.68 15.68 8.88  0.58 0.58 0.93 6.11 6.11 3.98 
USA, Michigan, Detroit, Whites 1973 -2007  (35) 0.67 1.74 4.39 10.13 9.56 6.42  0.10 0.22 0.64 4.49 3.76 2.93 
Switzerland, Vaud 1988 -2007  (20) 1.48 1.48 2.47 10.63 10.63 7.22  0.13 0.13 0.36 11.3 4.88 3.22 
USA, Michigan, Detroit, Blacks   1973 -2007  (35) 0.30 0.48 1.03 16.24 16.10 12.08  0.04 0.05 0.19 14.78 6.19 5.20 
Canada, Manitoba 1958 -2007  (50) 0.08 1.28 2.64 25.6 12.60 8.33  0.05 0.26 0.42 4.45 3.28 2.26 
England, North West 1979 -2007  (29) 1.58 3.70 7.07 22.32 17.76 10.12  0.46 0.86 1.34 10.01 7.74 4.08 
USA, SEER (9 Regs), Whites 1975 -2007  (33) 0.61 1.83 3.74 9.31 8.04 5.55  0.22 0.27 0.60 7.02 5.09 3.35 
Scotland, all 1975 -2007  (33) 2.36 3.42 7.47 21.17 18.56 9.72  0.83 1.05 1.49 10.64 7.90 4.57 
Australia, New South Wales 1983 -2007  (25) 0.71 1.54 2.67 12.36 10.82 7.54  0.00 0.26 0.50 8.03 6.46 3.68 
Canada, Saskatchewan 1968 -2007  (40) 0.13 1.20 1.99 14.2 8.51 5.93  0.00 0.00 0.31 18.15 19.07 13.53 
USA, Calif, Los Angel, Non-His Whites 1973 -2007  (35) 0.35 1.61 2.77 9.92 7.99 5.52  0.10 0.22 0.51 4.03 3.19 2.43 
Japan, Osaka 1963 -2007  (45) 0.00 0.22 0.41 107.06 70.42 44.19  0.15 0.25 0.03 23.39 17.19 14.11 
England, South & West 1979 -2007  (29) 1.40 3.46 5.84 17.21 14.79 7.02  0.30 0.48 1.11 6.99 3.77 2.72 
Japan, Miyagi 1978 -2007  (30) 0.68 0.43 0.69 82.51 84.41 65.72  0.05 0.19 0.10 8.44 7.09 5.20 
Slovakia, all                   1973 -2007  (35) 0.15 0.35 0.78 42.30 25.06 16.43  0.00 0.04 0.15 8.29 5.40 3.80 
India, Mumbai               1978 -2007  (30) 0.29 0.04 0.08 7.11 6.68 4.46  0.11 0.11 0.00 12.46 12.46 12.27 
USA, SEER (9 Regs), Blacks       1975 -2007  (33) 0.17 0.46 0.74 15.30 15.04 10.43  0.00 0.00 0.14 23.97 23.97 10.48 
Australia. Victoria 1983 -2007  (25) 1.23 1.74 2.64 14.84 12.33 7.97  0.12 0.20 0.45 5.27 4.40 3.47 
Colombia, Cali 1983 -2007  (25) 0.19 0.68 0.87 32.46 33.40 25.82  0.00 0.07 0.18 7.82 6.31 4.81 
Italy, Romagna 1988 -2007  (20) 0.44 0.44 0.45 41.78 41.78 20.34  0.23 0.05 0.03 38.26 34.52 22.21 
Singapore, Chinese 1968 -2007  (40) 0.00 0.28 0.38 45.07 33.48 14.90  0.00 0.00 0.03 4.48 4.79 4.17 
Denmark, all 1978 -2007  (30) 0.81 1.76 2.54 15.05 10.29 7.68  0.19 0.19 0.40 3.88 3.88 3.86 
Philippines, Manila      1983 -2007  (25) 0.32 0.34 0.45 14.16 11.72 6.91  0.00 0.02 0.04 17.21 15.12 7.86 
Italy, Torino 1985 -2007  (23) 0.41 0.55 0.82 20.25 19.18 10.65  0.00 0.00 0.16 8.94 9.15 5.40 
Costa Rica, all 1980 -2007  (28) 0.55 0.52 0.63 48.40 39.53 24.65  0.08 0.08 0.08 11.87 11.87 7.22 
USA, Calif, Los Angel, Blacks    1973 -2007  (35) 0.37 0.68 0.59 15.53 13.76 8.66  0.00 0.05 0.08 26.73 16.45 11.43 
France, Isere 1979 -2007  (29) 0.33 1.98 1.51 13.26 14.81 7.36  0.04 0.05 0.28 6.81 3.54 3.01 
USA, Calif, Los Angel, His Whites 1973 -2007  (35) 0.04 1.47 1.47 14.98 13.43 9.53  0.09 0.14 0.27 7.68 5.77 5.62 
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Table 3: Correlations between incidence (WASR) trends of esophageal adenocarcinoma and total gastric cancer  
In men in the two time periods- full range and 1989-2007. 
Study Population 
 
Population Full Range  1989 - 2007 
(2007) Period (yrs) CC P value  CC P value 
Brazil, Goiania 588132 1988 -2007  (20) 0.048 0.84  0.098 0.70 
Estonia, all 617828 1968 -2007  (40) -0.420 0.01  -0.471 0.04 
Thailand, Chiang Mai 741784 1983 -2007  (25) -0.281 0.17  -0.109 0.66 
Switzerland, St Gall-Appenzell 263298 1983 -2007  (25) -0.590 0.00  -0.519 0.02 
Israel, Jews 2674800 1963 -2007  (45) -0.637 0.00  -0.173 0.48 
Croatia, all 2137984 1988 -2007  (20) -0.737 0.00  -0.713 0.00 
Spain, Murcia 714667 1983 -2007  (25) -0.394 0.05  -0.382 0.11 
Austria, Tyrol 342794 1988 -2007  (20) -0.530 0.02  -0.475 0.04 
France, Bas-Rhin 534515 1975 -2007  (33) -0.536 0.00  -0.458 <0.05 
Spain, Granada 438332 1985 -2007  (23) -0.442 0.04  -0.396 0.09 
Netherlands, all 8100293 1989 -2007  (19) -0.961 0.00  -0.971 0.00 
USA, Michigan, Detroit, Whites 1390555 1973 -2007  (35) -0.921 0.00  -0.821 0.00 
Switzerland, Vaud 323759 1988 -2007  (20) -0.402 0.08  -0.370 0.12 
USA, Michigan, Detroit, Blacks 475552 1973 -2007  (35) -0.271 0.12  0.193 0.43 
Canada, Manitoba 588875 1958 -2007  (50) -0.777 0.00  -0.402 0.09 
England, North West 3223560 1979 -2007  (29) -0.926 0.00  -0.800 0.00 
USA, SEER (9 Regs), Whites 10682176 1975 -2007  (33) -0.972 0.00  -0.834 0.00 
Scotland, all 2485606 1975 -2007  (33) -0.961 0.00  -0.913 0.00 
Australia, New South Wales 3420484 1983 -2007  (25) -0.888 0.00  -0.810 0.00 
Canada, Saskatchewan 495639 1968 -2007  (40) -0.724 0.00  -0.083 0.73 
USA, Calif, Los Angel, Non-His Whites 1446148 1973 -2007  (35) -0.843 0.00  -0.520 0.02 
Japan, Osaka 4366616 1963 -2007  (45) -0.915 0.00  -0.572 0.01 
England, South & West 3442830 1979 -2007  (29) -0.924 0.00  -0.774 0.00 
Japan, Miyagi 1140676 1978 -2007  (30) -0.383 0.04  -0.574 0.01 
Slovakia, all 2621095 1973 -2007  (35) -0.818 0.00  -0.463 <0.05 
India, Mumbai 7479777 1978 -2007  (30) -0.425 0.02  -0.567 0.01 
USA, SEER (9 Regs), Blacks 1724091 1975 -2007  (33) -0.592 0.00  -0.434 0.06 
Australia. Victoria 2574901 1983 -2007  (25) -0.810 0.00  -0.593 0.01 
Colombia, Cali 1000036 1983 -2007  (25) 0.010 0.96  0.029 0.91 
Italy, Romagna 577247 1988 -2007  (20) -0.074 0.76  -0.192 0.43 
Singapore, Chinese 1324700 1968 -2007  (40) -0.558 0.00  -0.188 0.44 
Denmark, all 2704655 1978 -2007  (30) -0.930 0.00  -0.766 0.00 
Philippines, Manila 2993487 1983 -2007  (25) -0.371 0.07  -0.185 0.45 
Italy, Torino 435148 1985 -2007  (23) -0.341 0.11  0.048 0.84 
Costa Rica, all 2227538 1980 -2007  (28) -0.008 0.97  -0.419 0.07 
USA, Calif, Los Angel, Blacks 450132 1973 -2007  (35) -0.357 0.04  -0.155 0.53 
France, Isere 585746 1979 -2007  (29) 0.045 0.82  0.129 0.60 
USA, Calif, Los Angel, His Whites 2220592 1973 -2007  (35) -0.457 0.01  -0.076 0.76 
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Correlations between incidence rates (WASR) of EAC and gastric cancer in cross-sectional study in men.    
Note: Each dot represents a dataset from a country, 1a: EAC versus total gastric cancer, 1b. EAC versus 
non-cardia gastric cancers, 1c: visual clustering of countries divided into groups A-D.  
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Maps of countries color-coded with visual clustering of populations with different combinations of EAC and 
gastric cancer in cross-sectional study in men.  
Note: For each country, a pooled national data has been used to create colour codes. The grey code 
indicates no data available. A: TGC<15 & EAC≥5,   B: TGC<15 & 1.5≤EAC<5,   C: TGC<15 & EAC<1.5,   D: 
TGC≥15 & EAC<1.5.  
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Average Annual Percentage Changes (95% CI) of EAC versus TGC in men during short common period 
(1989-2007) of registration in populations.  
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Longitudinal data superimposed on cross-sectional cancer incidence by groups A-D in men.  
Incidence of esophageal adenocarcinoma is shown on Y axis (per 100,000py) and incidence of total gastric 
cancer on X axis. The cross-sectional data of the most recent cancer incidence for different countries is 
shown by dots.  For the three populations with the longest available longitudinal data, we have 
superimposed on the dot diagram a line indicating their incidence trend from start to end of registration 
period dates.  The dates of the start and end of the incidence trend line is given above in box and the time-
line is always from right to left  
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Supplementary Tables and Figures (revised on 22 Oct 2015) 
 
 
 
Table S1: Correlations between incidence (WASR) trends of esophageal adenocarcinoma and total gastric cancer in women in the 
two time periods- full range and 1989-2007. 
 
Study Population 
 
Period (yrs) Full Range  1989-2007 
CC P value  CC P value 
Brazil, Goiania 1988 -2007  (20) 0.071 0.77  -0.077 0.76 
Estonia, all 1968 -2007  (40) -0.428 0.01  -0.243 0.32 
Thailand, Chiang Mai 1983 -2007  (25) -0.463 0.02  -0.514 0.02 
Switzerland, St Gall-Appenzell 1983 -2007  (25) -0.270 0.19  -0.130 0.60 
Israel, Jews 1963 -2007  (45) -0.477 0.00  0.086 0.73 
Croatia, all 1988 -2007  (20) -0.155 0.51  -0.272 0.26 
Spain, Murcia 1983 -2007  (25) -0.014 0.95  0.122 0.62 
Austria, Tyrol 1988 -2007  (20) -0.159 0.50  -0.251 0.30 
France, Bas-Rhin 1975 -2007  (33) -0.523 0.00  -0.234 0.33 
Spain, Granada 1985 -2007  (23) -0.348 0.10  -0.222 0.36 
Netherlands, all 1989 -2007  (19) -0.853 0.00  -0.860 0.00 
USA, Michigan, Detroit, Whites 1973 -2007  (35) -0.716 0.00  -0.384 0.10 
Switzerland, Vaud 1988 -2007  (20) -0.104 0.66  0.011 0.97 
USA, Michigan, Detroit, Blacks 1973 -2007  (35) -0.295 0.09  -0.283 0.24 
Canada, Manitoba 1958 -2007  (50) -0.486 0.00  -0.175 0.47 
England, North West 1979 -2007  (29) -0.778 0.00  -0.452 0.05 
USA, SEER (9 Regs), Whites 1975 -2007  (33) -0.863 0.00  -0.612 0.01 
Scotland, all 1975 -2007  (33) -0.860 0.00  -0.400 0.09 
Australia, New South Wales 1983 -2007  (25) -0.680 0.00  -0.573 0.01 
Canada, Saskatchewan 1968 -2007  (40) -0.270 0.09  0.168 0.49 
USA, Calif, Los Angel, Non-His Whites 1973 -2007  (35) -0.730 0.00  -0.408 0.08 
Japan, Osaka 1963 -2007  (45) -0.667 0.00  -0.292 0.23 
England, South & West 1979 -2007  (29) -0.944 0.00  -0.849 0.00 
Japan, Miyagi 1978 -2007  (30) -0.171 0.37  0.237 0.33 
Slovakia, all 1973 -2007  (35) -0.607 0.00  -0.383 0.11 
India, Mumbai 1978 -2007  (30) -0.297 0.11  -0.529 0.02 
USA, SEER (9 Regs), Blacks 1975 -2007  (33) -0.429 0.01  -0.353 0.14 
Australia. Victoria 1983 -2007  (25) -0.610 0.00  -0.476 0.04 
Colombia, Cali 1983 -2007  (25) -0.373 0.07  -0.336 0.16 
Italy, Romagna 1988 -2007  (20) -0.470 0.04  -0.421 0.07 
Singapore, Chinese 1968 -2007  (40) -0.237 0.14  -0.096 0.70 
Denmark, all 1978 -2007  (30) -0.731 0.00  -0.246 0.31 
Philippines, Manila 1983 -2007  (25) 0.149 0.48  0.019 0.94 
Italy, Torino 1985 -2007  (23) -0.451 0.03  -0.251 0.30 
Costa Rica, all 1980 -2007  (28) 0.143 0.47  0.244 0.31 
USA, Calif, Los Angel, Blacks 1973 -2007  (35) -0.316 0.06  -0.075 0.76 
France, Isere 1979 -2007  (29) -0.032 0.87  0.118 0.63 
USA, Calif, Los Angel, His Whites 1973 -2007  (35) -0.419 0.01  -0.310 0.20 
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